Holland Jennifer E, Cassidy Adam R, Stopp Christian, White Matthew T, Bellinger David C, Rivkin Michael J, Newburger Jane W, DeMaso David R
Department of Psychiatry, Boston Children's Hospital, Boston, MA.
Department of Psychiatry, Boston Children's Hospital, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA.
J Pediatr. 2017 Aug;187:165-173. doi: 10.1016/j.jpeds.2017.04.048. Epub 2017 May 19.
To assess psychiatric disorders and function in adolescents with repaired tetralogy of Fallot (TOF) without and with a genetic diagnosis and to evaluate associations of functioning with medical factors, IQ, and demographics.
Adolescents with TOF (n = 91) and 87 healthy referents completed a clinician-rated structured psychiatric interview, parent-/self-report measures of psychopathology, and brain magnetic resonance imaging. Twenty-three of the adolescents with TOF had a known genetic diagnosis.
The prevalence of anxiety disorders did not differ significantly between adolescents with TOF without genetic diagnosis (n = 68) and referents. Adolescents with TOF and a genetic diagnosis showed an increased lifetime prevalence of anxiety disorder (43%) and lower global psychosocial functioning (median, 70; IQR, 63-75) compared with adolescents with TOF without genetic diagnosis (15% and 83; IQR, 79-87, respectively; P = .04 and <.001, respectively) and referents (6% and 85; IQR, 76-90, respectively; P = .001 and <.001, respectively). Adolescents with TOF without and with a genetic diagnosis had a higher lifetime prevalence of attention deficit-hyperactivity disorder (ADHD) than referents (19% and 39%, respectively, vs 5%; P = .04 and .002, respectively) and worse outcomes on parent-/self-report ratings of anxiety and disruptive behavior compared with referents. Risk factors for anxiety, ADHD, and lower psychosocial functioning for adolescents with TOF without a genetic diagnosis included older age, male sex, and low IQ. Medical variables were not predictive of psychiatric outcomes.
Adolescents with TOF, particularly those with a genetic diagnosis, show increased rates of psychiatric disorder and dysfunction. Continued mental health screening and surveillance into young adulthood is warranted for adolescents with TOF.
评估法洛四联症(TOF)修补术后青少年有无基因诊断情况下的精神障碍及功能,并评估功能与医学因素、智商及人口统计学特征之间的关联。
91例TOF青少年及87例健康对照完成了临床医生评定的结构化精神科访谈、父母/自我报告的精神病理学测量以及脑磁共振成像。其中23例TOF青少年有已知的基因诊断。
无基因诊断的TOF青少年(n = 68)与健康对照相比,焦虑症患病率无显著差异。与无基因诊断的TOF青少年(分别为15%和83;IQR,79 - 87,P = 0.04和<0.001)及健康对照(分别为6%和85;IQR,76 - 90,P = 0.001和<0.001)相比,有基因诊断的TOF青少年焦虑症终生患病率增加(43%),整体社会心理功能较低(中位数为70;IQR,63 - 75)。无基因诊断和有基因诊断的TOF青少年注意力缺陷多动障碍(ADHD)终生患病率均高于健康对照(分别为19%和39%,vs 5%;P分别为0.04和0.002),且与健康对照相比,父母/自我报告的焦虑和破坏性行为评分结果更差。无基因诊断的TOF青少年焦虑、ADHD及较低社会心理功能的危险因素包括年龄较大、男性及低智商。医学变量不能预测精神科结局。
TOF青少年,尤其是有基因诊断的青少年,精神障碍和功能障碍发生率增加。对TOF青少年持续进行心理健康筛查和监测直至成年早期是必要的。